The Federal Trade Commission said the deal would enable Amgen to exploit its size to block competition for two expensive Horizon drugs.
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to exploit its size to block competition for two expensive Horizon drugs.
